Serum level of vascular endothelial growth factor (VEGF) as an independent prognostic factor in metastatic renal cell carcinoma (MRCC)

被引：0
|
作者：
Negrier, S.
Chabaud, S.
Escudier, B.
Ravaud, A.
Chevreau, C.
Blay, J. Y.
Delva, R.
Biota, C.
Perol, D.
Menetrier-Caux, C.
机构：
[1] Ctr Leon Berard, Lyon, France
[2] Inst Gustave Roussy, Villejuif, France
[3] CHU Bordeaux, Bordeaux, France
[4] Ctr Claudius Regaud, Toulouse, France
[5] Hop Edouard Herriot, Lyon, France
[6] INSERM 590, Lyon, France
[7] Ctr Paul Papin, Angers, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5044
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Tumor burden as an independent prognostic factor in metastatic renal cell carcinoma (mRCC).
    Escudier, Bernard J.
    Iacovelli, Roberto
    Lanoy, Emilie
    Albiges, Laurence
    Fizazi, Karim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [2] Vascular endothelial growth factor as prognostic factor in renal cell carcinoma
    Jacobsen, J
    Rasmuson, T
    Grankvist, K
    Ljungberg, S
    [J]. JOURNAL OF UROLOGY, 2000, 163 (01): : 343 - 347
  • [3] Vascular endothelial growth factor (VEGF) is an independent prognostic factor in pT3 renal cell carcinomas
    Bensalah, K
    Rioux-Leclercq, N
    Leray, E
    Vincendeau, S
    Rodriguez, A
    Manunta, A
    Guillé, F
    Lobel, B
    Patard, JJ
    [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 468 - 468
  • [4] Vascular endothelial growth factor (VEGF) expression is a prognostic factor in renal cell carcinomas
    Paradis, V
    Eschwège, P
    Blanchet, P
    Ba, N
    Benoit, G
    Jardin, A
    Bedossa, P
    [J]. LABORATORY INVESTIGATION, 1999, 79 (01) : 103A - 103A
  • [5] Prognostic significance of serum hepatocyte growth factor in clear cell renal cell carcinoma : comparison with serum vascular endothelial growth factor
    Tanimoto, Shuji
    Fukumori, Tomoharu
    El-Moula, Gad
    Shiirevnyamba, Avirmed
    Kinouchi, Shinichiro
    Koizumi, Takahiro
    Nakanishi, Ryoichi
    Yamamoto, Yasuyo
    Taue, Ryuichi
    Yamaguchi, Kunihisa
    Nakatsuji, Hiroyoshi
    Kishimoto, Tomoteru
    Izaki, Hirofumi
    Oka, Natsuo
    Takahashi, Masayuki
    Kanayama, Hiro-Omi
    [J]. JOURNAL OF MEDICAL INVESTIGATION, 2008, 55 (1-2): : 106 - 111
  • [6] Expression of vascular endothelial growth factor (VEGF) and activated vascular endothelial growth factor receptors (VEGFR) in renal cell carcinoma
    Ha, Byeong Keun
    Park, Moonja Chung
    [J]. MODERN PATHOLOGY, 2006, 19 : 82 - 82
  • [7] Serum vascular endothelial growth factor (VEGF), a prognostic indicator in sarcoma and carcinoma patients
    Heits, F
    Katschinski, DM
    Wiedemann, GJ
    Weiss, C
    Jelkmann, W
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1997, 10 (02) : 333 - 337
  • [8] Serum-sodium as an independent prognostic factor in metastatic renal cell carcinoma
    Jeppesen, A. N.
    Jensen, H. K.
    Donskov, F.
    Marcussen, N.
    von der Maase, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Vascular endothelial growth factor (VEGF) therapy in metastatic renal cell carcinoma (mRCC): Differences between Asian and non-Asian patients.
    Wang, Ying
    Choueiri, Toni K.
    Lee, Jae-Lyun
    Tan, Min-Han
    Rha, Sun Young
    North, Scott A.
    Kollmannsberger, Christian K.
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [10] Tumor response is an independent prognostic factor in patients (pts) treated for metastatic renal cell carcinoma (mRCC)
    Gruenwald, V.
    Lin, X.
    Kalanovic, D.
    McKay, R.
    Perkins, J.
    Simantov, R.
    Choueiri, T.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S642 - S642
12345